CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
2x2 inch piece of 3M microfoam adhesiveother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06059417
NCT06059417N/ACompleted

Foam Tape Allergy a Sticky Situation

CHRISTUS Health·interventional·Posted Sep 28, 2023·Updated Jul 26, 2024

In Brief

A clinical study evaluating 2x2 inch piece of 3M microfoam adhesive for Medical Adhesive Allergy and 2 related conditions. Completed, enrolled 40 participants across 2 sites.

Detailed Summary

Foam tape is commonly used in the emergency department as a dressing over chest tubes owing to its occlusive and compressible properties. There is a paucity of data regarding the incidence of significant cutaneous reactions to this material. The investigators conducted a prospective trial to evaluate the incidence of dermatitis following application of foam tape to the upper arm of a cohort of healthy volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedSep 28, 2023
Enrollment StartAug 1, 2021
Primary CompletionSep 13, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.8 years ago

Interventions

2x2 inch piece of 3M microfoam adhesiveother

A 2x2 inch piece of 3M microfoam adhesive will be applied to the medial aspect of the subject's upper arm. The adhesive will remain in place for 48 hours at which time an investigator will remove the adhesive and assess the study area. A numerical value will be assigned based on the Cutaneous Irritancy Scoring System (CISS). The study site will be compared to the contra-lateral upper extremity at the end of the 48 hour period.